Muller et al. observed this phenomenon in breast cancer, and found that p53-R175H and p53-R273H enhance EGFR and integrin trafficking depending on the Rab-coupling protein (RCP), resulting in the activation of the EGFR and integrin pathway, and the promotion of cell migration and invasion [34]. The gene discussed is TP53; the disease is breast cancer.